(Total Views: 64)
Posted On: 09/17/2019 8:25:42 AM
Post# of 27449

$IMGN News Article - ImmunoGen to Present Full Data from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine and Initial Data from Phase 1b FORWARD II Triplet Cohort at ESMO https://marketwirenews.com/news-releases/immu...65046.html


My Twitter: WhyteStocks